Patterns and predictors of first and subsequent recurrence in women with early breast cancer

por Geurts, Y. M., Witteveen, A., Bretveld, R., Poortmans, P. M., Sonke, G. S., Strobbe, L. J. A., Siesling, S.
Publicado 2017

Enrichment of high-grade tumors in breast cancer gene expression studies

por van Seijen, M., Mooyaart, A. L., Mulder, L., Hoogstraat, M., Drukker, C. A., Loo, C. E., Pouw, B., Sonke, G. S., Wesseling, J., Lips, E. H.
Publicado 2017

Selecting the optimal position of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer – the SONIA study: study protocol for a randomized controlled trial

por van Ommen-Nijhof, A., Konings, I. R., van Zeijl, C. J. J., Uyl-de Groot, C. A., van der Noort, V., Jager, A., Sonke, G. S.
Publicado 2018

Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer

por Rigter, L S, Loo, C E, Linn, S C, Sonke, G S, van Werkhoven, E, Lips, E H, Warnars, H A, Doll, P K, Bruining, A, Mandjes, I A, Vrancken Peeters, M J, Wesseling, J, Gilhuijs, K G, Rodenhuis, S
Publicado 2013

Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib

por de Haan, R., van Werkhoven, E., van den Heuvel, M.M., Peulen, H. M. U., Sonke, G. S., Elkhuizen, P., van den Brekel, M. W. M., Tesselaar, M. E. T., Vens, C., Schellens, J. H. M., van Triest, B., Verheij, M.
Publicado 2019

BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer

por Liefaard, M. C., van der Voort, A., van Ramshorst, M. S., Sanders, J., Vonk, S., Horlings, H. M., Siesling, S., de Munck, L., van Leeuwen, A. E., Kleijn, M., Mittempergher, L., Kuilman, M. M., Glas, A. M., Wesseling, J., Lips, E. H., Sonke, G. S.
Publicado 2023

Unleashing NK- and CD8 T cells by combining monalizumab and trastuzumab for metastatic HER2-positive breast cancer: Results of the MIMOSA trial

por Geurts, V.C.M., Voorwerk, L., Balduzzi, S., Salgado, R., Van de Vijver, K., van Dongen, M.G.J., Kemper, I., Mandjes, I.A.M., Heuver, M., Sparreboom, W., Haanen, J.B.A.G., Sonke, G.S., Horlings, H.M., Kok, M.
Publicado 2023

Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant

por Neven, P., Fasching, P. A., Chia, S., Jerusalem, G., De Laurentiis, M., Im, S.-A., Petrakova, K., Bianchi, G. V., Martín, M., Nusch, A., Sonke, G. S., De la Cruz-Merino, L., Beck, J. T., Zarate, J. P., Wang, Y., Chakravartty, A., Wang, C., Slamon, D. J.
Publicado 2023

Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms

por Drukker, C. A., Nijenhuis, M. V., Bueno-de-Mesquita, J. M., Retèl, V. P., van Harten, W. H., van Tinteren, H., Wesseling, J., Schmidt, M. K., van’t Veer, L. J., Sonke, G. S., Rutgers, E. J. T., van de Vijver, M. J., Linn, S. C.
Publicado 2014

Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breas...

por Hortobagyi, G N, Stemmer, S M, Burris, H A, Yap, Y S, Sonke, G S, Paluch-Shimon, S, Campone, M, Petrakova, K, Blackwell, K L, Winer, E P, Janni, W, Verma, S, Conte, P, Arteaga, C L, Cameron, D A, Mondal, S, Su, F, Miller, M, Elmeliegy, M, Germa, C, O’Shaughnessy, J
Publicado 2019

Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring?

por Bouwer, N. I., Steenbruggen, T. G., van Rosmalen, J., Rier, H. N., Kitzen, J. J. E. M., van Bekkum, M. L., Tije, A. J. Ten, de Jong, P. C., Drooger, J. C., Holterhues, C., Smorenburg, C. H., Kofflard, M. J. M., Boersma, E., Sonke, G. S., Levin, M.-D., Jager, A.
Publicado 2021

Effect of physical exercise on the hippocampus and global grey matter volume in breast cancer patients: A randomized controlled trial (PAM study)

por Koevoets, E.W., Geerlings, M.I., Monninkhof, E.M., Mandl, R., Witlox, L., van der Wall, E., Stuiver, M.M., Sonke, G.S., Velthuis, M.J., Jobsen, J.J., van der Palen, J., Bos, M.E.M.M., Göker, E., Menke-Pluijmers, M.B.E., Sommeijer, D.W., May, A.M., de Ruiter, M.B., Schagen, S.B.
Publicado 2022

Effect of physical exercise on cognitive function after chemotherapy in patients with breast cancer: a randomized controlled trial (PAM study)

por Koevoets, E. W., Schagen, S. B., de Ruiter, M. B., Geerlings, M. I., Witlox, L., van der Wall, E., Stuiver, M. M., Sonke, G. S., Velthuis, M. J., Jobsen, J. J., Menke-Pluijmers, M. B. E., Göker, E., van der Pol, C. C., Bos, M. E. M. M., Tick, L. W., van Holsteijn, N. A., van der Palen, J., May, A. M., Monninkhof, E. M.
Publicado 2022